Jeff Terrell - Profile and Investment Details

Investor Profile

Jeff Terrell is a Venture Capital, Private Equity Firm, Investor based in Durham, North Carolina, United States with a diverse investment portfolio that includes companies such as Standard Bariatrics, Contego Medical, Inc., Contego Medical, Clearside Biomedical, Vigil Neuroscience, Artizan Biosciences, 410 Medical: LifeFlowMATI Energy, SpineAlign Medical, DropWorks, Inc., AtaCor Medical, Inc., Lysosomal Therapeutics, Endogenex, Kymera Therapeutics, Spyryx Biosciences, Bivarus, AtaCor Medical, Jumo Health, Clinipace, StrideBio, GrayBug, Nusirt, WalletFi, Ribometrix, Curoverse, Rodin Therapeutics, Medfusion, RapidPulse, GeneCentric Diagnostics, Boragen, Myeloid Therapeutics, Trefoil Therapeutics, Empliant, G1 Therapeutics, ArtusLabs, Clinverse, Elligo Health Research, Atsena Therapeutics, PhaseBio Pharmaceuticals, HistoSonics, Boston Immune Technologies & Therapeutics, NeuroTronik, Altis Biosystems, Viamet Pharmaceuticals, Coferon, Boomerang Medical, TetraLogic Pharmaceuticals, ORIG3N, 410 Medical, CVRx, Qpex Biopharma, Qvella Corporation, NurseGrid, Sideris Pharmaceuticals, Wildflower Health, Shattuck Labs, Cardiosense, . Over time, Jeff Terrell has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Jeff Terrell is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Patient Care, Health Care, Wellness, Women Founded, Android, Life Science, Portfolio Management, Information Technology (IT), Software, Biotechnology, Medical Devices, Clinical Trials, Health Diagnostics, Digital Health, Medical, Information Technology, B2B, Therapeutics, Molecular Diagnostics, Media and Entertainment, Diverse Founder Investments, Pharmaceuticals, Healthcare Technology may find it worthwhile to explore potential connections with Jeff Terrell, as their portfolio suggests a familiarity and interest in this area.

Understanding Jeff Terrell’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.